← Leaderboards
Omaida C Velazquez
University Of Pennsylvania
$7,997,904
Attributed
$12,106,879
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,106,879 · 9
By mechanism
R01$9,325,738 · 5
R33$1,140,505 · 1
K01$685,260 · 1
R61$533,251 · 1
R21$422,125 · 1
Top collaborators
- Zhao-Jun Liu8 shared
- Sylvia Daunert6 shared
- Roberto Irenardo Vazquez Padron5 shared
- Keith A Webster4 shared
- Maria Teresa Abreu2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- John P Lynch$7,638,617
- Daniel Sterman$5,215,085
- Bruce S Sachais$5,100,172
- Edward E Morrisey$54,694,196
- Rohan Palanki$178,372
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHealingStem CellsIn VivoMediatingBone MarrowCytokineRepairedPeripheral Arterial DiseaseEndothelial CellsBlood VesselsWound HealingSignal TransductionDiabetes MellitusAngiogenesisTissuesLigandsPreventClinically RelevantChronicLimb StructureNeovascularizationAmputationIn Vitro
Grant awards (35)
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$526,505
R33 · FY2024 · HL · contact PI
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$76,750
R33 · FY2024 · HL · contact PI
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$537,250
R33 · FY2023 · HL · contact PI
Targeted cell delivery for treatment of non-healing wounds and gangrene$731,645
R01 · FY2022 · HL
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$533,251
R61 · FY2022 · HL · contact PI
Targeted cell delivery for treatment of non-healing wounds and gangrene$731,645
R01 · FY2021 · HL
Targeted cell delivery for treatment of non-healing wounds and gangrene$739,013
R01 · FY2020 · HL
Targeted cell delivery for treatment of non-healing wounds and gangrene$617,490
R01 · FY2019 · HL
C-Kit in atherosclerosis$466,972
R01 · FY2019 · HL
C-Kit in atherosclerosis$466,401
R01 · FY2018 · HL
Role of Notch Signaling in atherosclerosis and Stem Cell Mediated Arterial Repair$537,609
R01 · FY2017 · HL · contact PI
C-Kit in atherosclerosis$383,750
R01 · FY2017 · HL
Nanocarrier-targeted mesenchymal stem cells to treat inflammatory bowel disease$191,875
R21 · FY2017 · AI
C-Kit in Atherosclerosis$82,098
R01 · FY2017 · HL
Role of Notch Signaling in atherosclerosis and Stem Cell Mediated Arterial Repair$535,697
R01 · FY2016 · HL · contact PI
C-Kit in atherosclerosis$383,750
R01 · FY2016 · HL
Nanocarrier-targeted mesenchymal stem cells to treat inflammatory bowel disease$230,250
R21 · FY2016 · AI
Role of Notch Signaling in atherosclerosis and Stem Cell Mediated Arterial Repair$551,552
R01 · FY2015 · HL · contact PI
Role of Notch Signaling in atherosclerosis and Stem Cell Mediated Arterial Repair$521,269
R01 · FY2014 · HL · contact PI
Recruiting activated endothellal progenitor cells to wounds by hyperoxia & SDF-1a$261,138
R01 · FY2011 · GM · contact PI
Bone marrow-derived fibroblasts in skin wound healing$266,651
R01 · FY2010 · DK · contact PI
Recruiting activated endothellal progenitor cells to wounds by hyperoxia & SDF-1a$264,542
R01 · FY2010 · GM · contact PI
Bone marrow-derived fibroblasts in skin wound healing$129,787
R01 · FY2010 · DK · contact PI
Bone marrow-derived fibroblasts in skin wound healing$269,344
R01 · FY2009 · DK · contact PI
Recruiting activated endothellal progenitor cells to wounds by hyperoxia & SDF-1a$267,965
R01 · FY2009 · GM · contact PI
Recruiting activated endothellal progenitor cells to wounds by hyperoxia & SDF-1a$279,161
R01 · FY2008 · GM · contact PI
Bone marrow-derived fibroblasts in skin wound healing$265,333
R01 · FY2008 · DK · contact PI
Bone marrow-derived fibroblasts in skin wound healing$155,601
R01 · FY2007 · DK · contact PI
Endothelial Progenitor Cells in Ischemic Wound Healing$137,052
K01 · FY2007 · HL · contact PI
Bone marrow-derived fibroblasts in skin wound healing$126,875
R01 · FY2007 · DK · contact PI
Bone marrow-derived fibroblasts in skin wound healing$290,450
R01 · FY2006 · DK · contact PI
Endothelial Progenitor Cells in Ischemic Wound Healing$137,052
K01 · FY2006 · HL · contact PI
Endothelial Progenitor Cells in Ischemic Wound Healing$137,052
K01 · FY2005 · HL
Endothelial Progenitor Cells in Ischemic Wound Healing$137,052
K01 · FY2004 · HL
Endothelial Progenitor Cells in Ischemic Wound Healing$137,052
K01 · FY2003 · HL